World News | Michelle Fay Cortez | Wednesday November 23, 2022
US regulators approved CSL Behring's hemophilia B gene therapy, a one-off infusion that frees patients from regular treatments but costs $3.5 million a dose, making it the most expensive medicine in the world.
www.ndtv.com